Jeffrey E. Russel

Array ( [id] => 4409476 [patent_doc_number] => 06310039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Antineoplastic conjugates of transferrin, albumin and polyethylene glycol' [patent_app_type] => 1 [patent_app_number] => 9/254598 [patent_app_country] => US [patent_app_date] => 1999-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14733 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310039.pdf [firstpage_image] =>[orig_patent_app_number] => 254598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1554188 [patent_doc_number] => 06348568 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Hybrid polypeptides with enhanced pharmacokinetic properties' [patent_app_type] => B1 [patent_app_number] => 09/315304 [patent_app_country] => US [patent_app_date] => 1999-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 35 [patent_no_of_words] => 25350 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348568.pdf [firstpage_image] =>[orig_patent_app_number] => 09315304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1114834 [patent_doc_number] => 06800296 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Modification of surfaces using biological recognition events' [patent_app_type] => B1 [patent_app_number] => 09/314540 [patent_app_country] => US [patent_app_date] => 1999-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 6763 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800296.pdf [firstpage_image] =>[orig_patent_app_number] => 09314540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420082 [patent_doc_number] => 06506725 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Ultra pure hemoglobin solutions and blood-substitutes' [patent_app_type] => B1 [patent_app_number] => 09/309069 [patent_app_country] => US [patent_app_date] => 1999-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 35528 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506725.pdf [firstpage_image] =>[orig_patent_app_number] => 09309069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600865 [patent_doc_number] => 06475988 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Methods to increase white blood cell survival after chemotherapy' [patent_app_type] => B1 [patent_app_number] => 09/307940 [patent_app_country] => US [patent_app_date] => 1999-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8349 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475988.pdf [firstpage_image] =>[orig_patent_app_number] => 09307940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901657 [patent_doc_number] => 20010023240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS' [patent_app_type] => new [patent_app_number] => 09/305506 [patent_app_country] => US [patent_app_date] => 1999-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11074 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20010023240.pdf [firstpage_image] =>[orig_patent_app_number] => 09305506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640657 [patent_doc_number] => 06395254 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Conjugate comprising an active agent, a polypeptide and a polyether' [patent_app_type] => B1 [patent_app_number] => 09/308103 [patent_app_country] => US [patent_app_date] => 1999-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2218 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395254.pdf [firstpage_image] =>[orig_patent_app_number] => 09308103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477879 [patent_doc_number] => 06344442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-02-05 [patent_title] => 'Zona pellucida proteins for contraception' [patent_app_type] => B2 [patent_app_number] => 09/194062 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3386 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344442.pdf [firstpage_image] =>[orig_patent_app_number] => 09194062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409609 [patent_doc_number] => 06300314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Hematopoietic stimulation' [patent_app_type] => 1 [patent_app_number] => 9/304199 [patent_app_country] => US [patent_app_date] => 1999-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 9910 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300314.pdf [firstpage_image] =>[orig_patent_app_number] => 304199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408599 [patent_doc_number] => 06239107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP)' [patent_app_type] => 1 [patent_app_number] => 9/171654 [patent_app_country] => US [patent_app_date] => 1999-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 30 [patent_no_of_words] => 20185 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239107.pdf [firstpage_image] =>[orig_patent_app_number] => 171654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575085 [patent_doc_number] => 06468978 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Active hedgehog protein conjugate' [patent_app_type] => B1 [patent_app_number] => 09/301199 [patent_app_country] => US [patent_app_date] => 1999-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10620 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468978.pdf [firstpage_image] =>[orig_patent_app_number] => 09301199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4349540 [patent_doc_number] => 06214790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Neo-tryptophan' [patent_app_type] => 1 [patent_app_number] => 9/289693 [patent_app_country] => US [patent_app_date] => 1999-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16767 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214790.pdf [firstpage_image] =>[orig_patent_app_number] => 289693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186356 [patent_doc_number] => 06042822 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Interferon polymer conjugates' [patent_app_type] => 1 [patent_app_number] => 9/287476 [patent_app_country] => US [patent_app_date] => 1999-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9211 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042822.pdf [firstpage_image] =>[orig_patent_app_number] => 287476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1209652 [patent_doc_number] => 06713449 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'E2F activity inhibitory compounds' [patent_app_type] => B1 [patent_app_number] => 09/269576 [patent_app_country] => US [patent_app_date] => 1999-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10927 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713449.pdf [firstpage_image] =>[orig_patent_app_number] => 09269576 [rel_patent_id] =>[rel_patent_doc_number] =>)